2024 HCPCS Code J2779
Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
TAGS: implant intravitreal
Short Description | Inj, susvimo 0.1 mg |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | July 01, 2022 |
HCPCS Code Added Date | July 01, 2022 |
HCPCS Pricing Indicator Code | 51 - Drugs |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J3420 - Vitamin b12 injection
- J3424 - Inj hydroxocobalamin iv 25mg
- J3425 - Hydroxocobalamin im 10mcg
- J3430 - Vitamin k phytonadione inj
- J3465 - Injection, voriconazole
- J3470 - Hyaluronidase injection
- J3471 - Ovine, up to 999 usp units
- J3472 - Ovine, 1000 usp units
- J3473 - Hyaluronidase recombinant
- J3475 - Inj magnesium sulfate
- J3480 - Inj potassium chloride
- J3485 - Zidovudine
- J3486 - Ziprasidone mesylate
- J3489 - Zoledronic acid 1mg
- J3490 - Drugs unclassified injection
- J3520 - Edetate disodium per 150 mg
- J3530 - Nasal vaccine inhalation
- J3535 - Metered dose inhaler drug
- J3570 - Laetrile amygdalin vit b17
- J3590 - Unclassified biologics